Thereupon, a positive correlation between proBDNF, BDNF, and total sleep time in OSA and a higher level of expression of studied proteins in OSA individuals with poor sleep quality and insomnia symptoms indicate that patients afflicted with this disease might develop specific compensational mechanisms which are associated with increased expression of studied neurotrophins. The gene discussed is BDNF; the disease is insomnia.